Serum Anti-mullerian Hormone and Polycystic Ovarian Syndrome

PHASE2CompletedINTERVENTIONAL
Enrollment

50

Participants

Timeline

Start Date

January 1, 2015

Primary Completion Date

September 30, 2016

Study Completion Date

November 30, 2016

Conditions
Polycystic Ovary Syndrome
Interventions
PROCEDURE

Laparoscopic ovarian drilling

The electric current used was set at 40 Watts. The power was activated just before touching the ovary, and then the needle electrode was held against the antimesenteric surface of the ovary for 4 seconds until penetration of the ovarian capsule. Four or eight puncture points were made through the ovarian capsule of each ovary according to the study protocol. The ovaries were cooled in the pool of the Ringer's lactate after each cauterization both to minimize adhesion formation and to prevent heat trauma to the adjacent viscera. Complete hemostasis was ensured. At the end of the procedure, the ovaries were copiously rinsed with Ringer's lactate (Aqua-purator, Storz, Germany). An amount about 200 ml of heparinized Ringers lactate (5000 IU/1000 ml) was left in the pelvis to avoid postoperative adhesions.

BIOLOGICAL

Antimullerian hormone

"1. In patients with Antimullerian hormone between 4-8 ng/ml 4 punctures in each ovary were performed.~2. In patients with Antimullerian hormone above 8 ng/ml 8 punctures in each ovary were performed."

Trial Locations (1)

71111

Women Health Hospital - Assiut university, Asyut

All Listed Sponsors
lead

Assiut University

OTHER

NCT03237312 - Serum Anti-mullerian Hormone and Polycystic Ovarian Syndrome | Biotech Hunter | Biotech Hunter